فانكومايسين-تي إف (فانكومايسين)

معلومات اساسية

• متاح على:
• English
• العربية

Claribaccin is a pharmaceutical product that contains the active ingredient clarithromycin. Clarithromycin is a semisynthetic macrolide antibiotic that is derived by replacing the hydroxyl group at position CN3O with an (OH) group in the 6th position of the lactone ring of erythromycin. In other words, clarithromycin is a modified form of erythromycin known as 6-Omethylerythromycin A.

The main industry in which Claribaccin operates is the healthcare and pharmaceutical industry. This product is specifically designed to treat bacterial infections by targeting sensitive bacteria. Clarithromycin exerts its antibacterial action by binding to the 50S ribosomal subunit in bacteria, which prevents the translocation of activated amino acids. This interference with the bacterial protein synthesis process inhibits the growth and survival of susceptible microorganisms, leading to an effective antibacterial action.

The mechanism of action of clarithromycin is crucial in the treatment of various infections caused by susceptible bacteria. By inhibiting intracellular protein synthesis, Claribaccin helps to combat the growth and spread of harmful microorganisms. It is important to note that Claribaccin is only effective against bacteria that are sensitive to clarithromycin.

Overall, Claribaccin plays a significant role in the healthcare industry as a potent antibiotic medication that can effectively treat bacterial infections by inhibiting protein synthesis in susceptible microorganisms.